UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of
1934
Date of Report (Date of earliest event reported) March 14, 1995.
MAXICARE HEALTH PLANS, INC.
-------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-12024 95-3615709
-------------------------------------------------------------------
(Name or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1149 South Broadway Street, Los Angeles, California 90015
-------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (213) 765-2000
----------------
1 of 3
<PAGE>
Item 5. Other Events
Maxicare Health Plans, Inc. (the "Company") concluded the
redemption of its Series A Cumulative Convertible
Preferred Stock ("Series A Stock") on March 14, 1995 (the
"Redemption Date"). Holders of approximately 2.27 million
shares of Series A Stock converted their shares into
approximately 6.25 million shares of the Company's Common
Stock. After the Redemption Date, the remaining 21,000
shares of Series A Stock are no longer deemed to be
outstanding and holders of Series A Stock certificates are
entitled to receive only $25.4625 per share, which
represents the redemption price of $25.00 per share plus
accrued and unpaid dividends of $.4625 per share, without
additional interest thereon when they surrender the Series
A Stock Share certificates properly endorsed to American
Stock Transfer & Trust Company, the Redemption Agent.
As of March 14, 1995, the Company had approximately 17.30
million shares of Common Stock outstanding.
2 of 3
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
Maxicare Health Plans, Inc.
---------------------------------
(Registrant)
March 14, 1995 By /s/ EUGENE L. FROELICH
---------------------------------
Eugene L. Froelich
Chief Financial Officer
and Executive Vice President -
Finance and Administration
3 of 3
